AXA S.A.

SEC CIK: 0000898427
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KDNY holding history

Chinook Therapeutics, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KDNY overview All 13F holders of KDNY Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2021

Holdings of KDNY by AXA S.A., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−13,200−100.0%	Sold out	Holders
Q1 2022	13,200	$216.0K	<0.1%	−5,900−30.9%	Reduced	Holders
Q4 2021	19,100	$312.0K	<0.1%	−4,400−18.7%	Reduced	Holders
Q3 2021	23,500	$300.0K	<0.1%	+23,500	New	Holders